ASML vs G

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

Genpact presents a classic value-trap profile, characterized by a stable Piotroski F-Score of 4/9 and a current price ($34.32) trading very close to its Graham Number ($32.47). While the company maintains a strong ROE of 22.37% and a very attractive forward P/E of 7.73, these fundamentals are offset by a disastrous technical trend (0/100) and bearish insider activity. The core business faces significant existential risks from generative AI, which the 10-K explicitly notes could replace existing services and reduce demand. Consequently, the deep valuation discount is likely a reflection of the market pricing in structural industry disruption.